BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22772967)

  • 1. Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells.
    Kraguljac Kurtović N; Krajnović M; Bogdanović A; Suvajdžić N; Jovanović J; Dimitrijević B; Colović M; Krtolica K
    Med Oncol; 2012 Dec; 29(5):3547-56. PubMed ID: 22772967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.
    Krajnović M; Radojković M; Davidović R; Dimitrijević B; Krtolica K
    Med Oncol; 2013 Mar; 30(1):441. PubMed ID: 23275143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p15 promoter methylation - a novel prognostic marker in glioblastoma patients.
    Wemmert S; Bettscheider M; Alt S; Ketter R; Kammers K; Feiden W; Steudel WI; Rahnenführer J; Urbschat S
    Int J Oncol; 2009 Jun; 34(6):1743-8. PubMed ID: 19424593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease.
    Krajnović M; Jovanović MP; Mihaljević B; Anđelić B; Tarabar O; Knežević-Ušaj S; Krtolica K
    Clin Transl Sci; 2014 Oct; 7(5):384-90. PubMed ID: 24815848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
    Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p15
    Baba SM; Azad NA; Shah ZA; Dil-Afroze ; Pandith AA; Jan A; Aziz SA
    Cancer Res Treat; 2017 Jul; 49(3):790-797. PubMed ID: 28052659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.
    Rivera AL; Pelloski CE; Gilbert MR; Colman H; De La Cruz C; Sulman EP; Bekele BN; Aldape KD
    Neuro Oncol; 2010 Feb; 12(2):116-21. PubMed ID: 20150378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas.
    Buttarelli FR; Massimino M; Antonelli M; Lauriola L; Nozza P; Donofrio V; Arcella A; Oliva MA; Di Rocco C; Giangaspero F
    Childs Nerv Syst; 2010 Aug; 26(8):1051-6. PubMed ID: 20552207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
    Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
    Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
    Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.
    Melguizo C; Prados J; González B; Ortiz R; Concha A; Alvarez PJ; Madeddu R; Perazzoli G; Oliver JA; López R; Rodríguez-Serrano F; Aránega A
    J Transl Med; 2012 Dec; 10():250. PubMed ID: 23245659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p15 (INK4B) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid leukemia.
    El-Shakankiry NH; Mossallam GI
    J Egypt Natl Canc Inst; 2006 Sep; 18(3):227-32. PubMed ID: 17671532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients.
    Majchrzak-Celińska A; Paluszczak J; Kleszcz R; Magiera M; Barciszewska AM; Nowak S; Baer-Dubowska W
    J Appl Genet; 2013 Aug; 54(3):335-44. PubMed ID: 23661397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of nine tumor suppressor genes in multiple myeloma.
    Braggio E; Maiolino A; Gouveia ME; Magalhães R; Souto Filho JT; Garnica M; Nucci M; Renault IZ
    Int J Hematol; 2010 Jan; 91(1):87-96. PubMed ID: 20037750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
    Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
    Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry.
    Trabelsi S; Mama N; Ladib M; Karmeni N; Haddaji Mastouri M; Chourabi M; Mokni M; Tlili K; Krifa H; Yacoubi MT; Saad A; H'mida Ben Brahim D
    Clin Transl Oncol; 2016 Apr; 18(4):391-7. PubMed ID: 26289551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication.
    Solomon PR; Munirajan AK; Tsuchida N; Muthukumarasamy K; Rathinavel A; Selvam GS; Shanmugam G
    Indian J Med Res; 2008 Jan; 127(1):52-7. PubMed ID: 18316853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma.
    Sonoda Y; Yokosawa M; Saito R; Kanamori M; Yamashita Y; Kumabe T; Watanabe M; Tominaga T
    Int J Clin Oncol; 2010 Aug; 15(4):352-8. PubMed ID: 20232102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
    Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
    Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.